Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Small fee from Boston Scientific. BACKGROUND: The use of subcutaneous defibrillator (S-ICD) is a viable alternative to transvenous ICD in patients with Arrhythmogenic Cardiomyopathy (ACM). In transvenous ICD...

Descripción completa

Detalles Bibliográficos
Autores principales: Martignani, C, Spadotto, A, Graziosi, M, Massaro, G, Pollini, C, Angeletti, A, Ziacchi, M, Biagini, E, Biffi, M, Diemberger, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207279/
http://dx.doi.org/10.1093/europace/euad122.434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207279/
http://dx.doi.org/10.1093/europace/euad122.434

Ejemplares similares